Perdagangan PLx Pharma Inc. - PLXP CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.05 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024068% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.001846% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 0.58 |
Open* | 0.54 |
1-Year Change* | 42.11% |
Day's Range* | 0.38 - 0.54 |
52 wk Range | 0.13-4.71 |
Average Volume (10 days) | 216.99K |
Average Volume (3 months) | 8.18M |
Market Cap | 3.94M |
P/E Ratio | -100.00K |
Shares Outstanding | 29.14M |
Revenue | 4.54M |
EPS | -0.99 |
Dividend (Yield %) | N/A |
Beta | 3.86 |
Next Earnings Date | Mar 21, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 11, 2022 | 0.38 | -0.16 | -29.63% | 0.54 | 0.54 | 0.38 |
Nov 10, 2022 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Nov 9, 2022 | 0.57 | 0.00 | 0.00% | 0.57 | 0.59 | 0.57 |
Nov 8, 2022 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Nov 7, 2022 | 0.63 | 0.07 | 12.50% | 0.56 | 0.63 | 0.56 |
Nov 4, 2022 | 0.60 | -0.01 | -1.64% | 0.61 | 0.67 | 0.56 |
Nov 3, 2022 | 0.61 | 0.03 | 5.17% | 0.58 | 0.62 | 0.58 |
Nov 2, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.61 | 0.57 |
Nov 1, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.59 | 0.57 |
Oct 31, 2022 | 0.59 | 0.00 | 0.00% | 0.59 | 0.60 | 0.57 |
Oct 28, 2022 | 0.58 | 0.02 | 3.57% | 0.56 | 0.60 | 0.56 |
Oct 27, 2022 | 0.56 | 0.00 | 0.00% | 0.56 | 0.57 | 0.56 |
Oct 26, 2022 | 0.57 | 0.03 | 5.56% | 0.54 | 0.57 | 0.54 |
Oct 25, 2022 | 0.53 | -0.02 | -3.64% | 0.55 | 0.56 | 0.52 |
Oct 24, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 21, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 20, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 19, 2022 | 0.58 | 0.01 | 1.75% | 0.57 | 0.61 | 0.57 |
Oct 18, 2022 | 0.57 | -0.02 | -3.39% | 0.59 | 0.59 | 0.55 |
Oct 17, 2022 | 0.56 | 0.03 | 5.66% | 0.53 | 0.59 | 0.53 |
PLx Pharma Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | 8.208 | 0.03043 | 0.56546 | 0.75311 | 0.77866 |
Revenue | 8.208 | 0.03043 | 0.56546 | 0.75311 | 0.77866 |
Total Operating Expense | 48.998 | 13.4895 | 14.7678 | 11.7143 | 16.6265 |
Selling/General/Admin. Expenses, Total | 40.011 | 9.15057 | 10.0266 | 7.7916 | 10.175 |
Research & Development | 4.182 | 4.33897 | 4.74113 | 3.92267 | 4.15745 |
Unusual Expense (Income) | 0 | 2.29405 | |||
Operating Income | -40.79 | -13.4591 | -14.2023 | -10.9612 | -15.8478 |
Interest Income (Expense), Net Non-Operating | -5.335 | -1.75154 | -6.3001 | 11.8576 | -0.41889 |
Net Income Before Taxes | -46.125 | -15.2107 | -20.5024 | 0.89648 | -16.2667 |
Net Income After Taxes | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Net Income Before Extra. Items | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Net Income | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Income Available to Common Excl. Extra. Items | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Income Available to Common Incl. Extra. Items | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Diluted Net Income | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Diluted Weighted Average Shares | 23.6505 | 9.71495 | 8.91619 | 8.73322 | 7.02048 |
Diluted EPS Excluding Extraordinary Items | -2.05704 | -1.74452 | -3.84169 | 0.10265 | -2.18599 |
Diluted Normalized EPS | -2.05704 | -1.74452 | -3.84169 | 0.10265 | -1.9736 |
Total Adjustments to Net Income | -2.525 | -1.7373 | -13.7508 | ||
Cost of Revenue, Total | 4.805 | ||||
Gross Profit | 3.403 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 2.083 | 1.5919 | 6.6161 | 0 | 0 |
Revenue | 2.083 | 1.5919 | 6.6161 | 0 | 0 |
Total Operating Expense | 20.279 | 22.4437 | 16.4779 | 6.48048 | 3.59583 |
Selling/General/Admin. Expenses, Total | 18.456 | 20.8637 | 11.0132 | 5.49775 | 2.63633 |
Research & Development | 0.654 | 0.68778 | 1.55199 | 0.98273 | 0.9595 |
Operating Income | -18.196 | -20.8518 | -9.86185 | -6.48048 | -3.59583 |
Interest Income (Expense), Net Non-Operating | 7.411 | 24.4142 | -11.7807 | -10.0239 | -7.94468 |
Net Income Before Taxes | -10.785 | 3.56237 | -21.6425 | -16.5044 | -11.5405 |
Net Income After Taxes | -10.785 | 3.56237 | -21.6425 | -16.5044 | -11.5405 |
Net Income Before Extra. Items | -10.785 | 3.56237 | -21.6425 | -16.5044 | -11.5405 |
Net Income | -10.785 | 3.56237 | -21.6425 | -16.5044 | -11.5405 |
Total Adjustments to Net Income | 0 | -0.00004 | 0 | -2.20269 | -0.32227 |
Income Available to Common Excl. Extra. Items | -10.785 | 3.56233 | -21.6425 | -18.7071 | -11.8628 |
Income Available to Common Incl. Extra. Items | -10.785 | 3.56233 | -21.6425 | -18.7071 | -11.8628 |
Diluted Net Income | -10.785 | 3.56233 | -21.6425 | -18.7071 | -11.8628 |
Diluted Weighted Average Shares | 27.5392 | 27.5742 | 26.9119 | 23.6382 | 16.3616 |
Diluted EPS Excluding Extraordinary Items | -0.39162 | 0.12919 | -0.8042 | -0.79139 | -0.72504 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.39162 | 0.12919 | -0.8042 | -0.79139 | -0.72504 |
Cost of Revenue, Total | 1.169 | 0.89226 | 3.91274 | ||
Gross Profit | 0.914 | 0.69964 | 2.70336 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 73.476 | 22.9855 | 14.2833 | 14.8654 | 25.69 |
Cash and Short Term Investments | 69.392 | 22.4487 | 14.0013 | 14.2503 | 24.4044 |
Cash & Equivalents | 69.392 | 22.4487 | 14.0013 | 14.2503 | 24.4044 |
Total Receivables, Net | 0.634 | 0 | 0.01868 | 0.01823 | 0.01938 |
Accounts Receivable - Trade, Net | 0.634 | 0 | 0.01868 | 0.01823 | 0.01938 |
Total Inventory | 2.458 | 0.14338 | 0 | 0.24637 | |
Prepaid Expenses | 0.992 | 0.39347 | 0.26327 | 0.40937 | 0.30017 |
Other Current Assets, Total | 0 | 0.18754 | 0.71967 | ||
Total Assets | 76.642 | 26.6166 | 18.5028 | 18.3884 | 28.8486 |
Property/Plant/Equipment, Total - Net | 1.088 | 1.55304 | 2.0848 | 1.39423 | 1.02988 |
Goodwill, Net | 2.061 | 2.06102 | 2.06102 | 2.06102 | 2.06102 |
Intangibles, Net | |||||
Other Long Term Assets, Total | 0.017 | 0.01704 | 0.07367 | 0.06771 | 0.06771 |
Total Current Liabilities | 11.879 | 3.54231 | 6.09343 | 4.73266 | 1.81569 |
Payable/Accrued | 10.6 | 0.86257 | 0.92892 | 0.65305 | 0.85216 |
Accrued Expenses | 1.278 | 2.02327 | 1.50639 | 1.1699 | 0.96354 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 24.962 | 16.1636 | 16.9331 | 11.9441 | 24.2322 |
Total Long Term Debt | 0 | 0 | 0.62227 | 4.28039 | 6.94215 |
Other Liabilities, Total | 13.083 | 12.6213 | 10.2174 | 2.93104 | 15.4743 |
Total Equity | 51.68 | 10.453 | 1.56962 | 6.44429 | 4.61639 |
Common Stock | 0.028 | 0.01391 | 0.00916 | 0.00874 | 0.00872 |
Additional Paid-In Capital | 183.912 | 91.203 | 74.8371 | 72.8713 | 71.9399 |
Retained Earnings (Accumulated Deficit) | -148.274 | -102.149 | -86.9382 | -66.4358 | -67.3323 |
Total Liabilities & Shareholders’ Equity | 76.642 | 26.6166 | 18.5028 | 18.3884 | 28.8486 |
Total Common Shares Outstanding | 27.5392 | 13.9116 | 9.15626 | 8.74395 | 8.72282 |
Property/Plant/Equipment, Total - Gross | 1.553 | 2.00154 | 2.52769 | 1.68631 | 1.479 |
Accumulated Depreciation, Total | -0.465 | -0.4485 | -0.44288 | -0.29208 | -0.44912 |
Long Term Debt | 0 | 0.62227 | 4.28039 | 6.94215 | |
Current Port. of LT Debt/Capital Leases | 0 | 0.62227 | 3.65812 | 2.90971 | |
Preferred Stock - Non Redeemable, Net | 16.014 | 21.3849 | 13.6616 | ||
Other Current Liabilities, Total | 0.001 | 0.03421 | |||
Total Preferred Shares Outstanding | 0.01501 | 0.023 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 57.748 | 73.476 | 88.6142 | 82.013 | 84.8674 |
Cash and Short Term Investments | 52.499 | 69.392 | 82.5543 | 80.1695 | 84.4235 |
Cash & Equivalents | 52.499 | 69.392 | 82.5543 | 80.1695 | 84.4235 |
Total Inventory | 3.839 | 2.458 | 2.19035 | 1.26248 | 0.14338 |
Prepaid Expenses | 0.712 | 0.992 | 0.61625 | 0.58101 | 0.30056 |
Total Assets | 60.858 | 76.642 | 91.8361 | 85.3085 | 88.3209 |
Property/Plant/Equipment, Total - Net | 1.032 | 1.088 | 1.14378 | 1.21751 | 1.37546 |
Goodwill, Net | 2.061 | 2.061 | 2.06102 | 2.06102 | 2.06102 |
Other Long Term Assets, Total | 0.017 | 0.017 | 0.01704 | 0.01704 | 0.01704 |
Total Current Liabilities | 13.23 | 11.879 | 7.40538 | 3.06477 | 1.40919 |
Payable/Accrued | 12.716 | 10.6 | 6.45217 | 2.38232 | 0.96261 |
Accrued Expenses | 0.51113 | 1.278 | 0.95321 | 0.64824 | 0.41238 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 0.00287 | 0.001 | 0.03421 | 0.03421 | |
Total Liabilities | 18.875 | 24.962 | 44.9288 | 29.1794 | 22.2751 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 5.645 | 13.083 | 37.5234 | 26.1146 | 20.8659 |
Total Equity | 41.983 | 51.68 | 46.9073 | 56.1292 | 66.0459 |
Preferred Stock - Non Redeemable, Net | 16.014 | 16.014 | 16.0136 | 16.0136 | 21.3849 |
Common Stock | 0.028 | 0.028 | 0.02748 | 0.02615 | 0.02284 |
Additional Paid-In Capital | 185 | 183.912 | 182.702 | 170.283 | 158.327 |
Retained Earnings (Accumulated Deficit) | -159.059 | -148.274 | -151.836 | -130.194 | -113.689 |
Total Liabilities & Shareholders’ Equity | 60.858 | 76.642 | 91.8361 | 85.3085 | 88.3209 |
Total Common Shares Outstanding | 27.5392 | 27.5392 | 27.477 | 26.145 | 22.8363 |
Total Preferred Shares Outstanding | 0.01501 | 0.01501 | 0.01501 | 0.01501 | 0.023 |
Total Receivables, Net | 0.698 | 0.634 | 3.25331 | ||
Accounts Receivable - Trade, Net | 0.698 | 0.634 | 3.25331 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Cash From Operating Activities | -32.118 | -12.2436 | -12.659 | -9.49923 | -13.3066 |
Cash From Operating Activities | 0.116 | 0.12462 | 0.15825 | 0.20096 | 0.02984 |
Deferred Taxes | 0 | -0.92 | |||
Non-Cash Items | 8.38 | 3.04205 | 6.8139 | -10.8456 | 4.91663 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0.006 | 0.21286 | 0.6003 | 0.67115 | 0.19594 |
Changes in Working Capital | 5.511 | -0.19961 | 0.8712 | 0.24895 | -1.9863 |
Cash From Investing Activities | 0.095 | -0.102 | -0.23029 | -0.65487 | 11.2389 |
Capital Expenditures | 0 | -0.102 | -0.24174 | -0.65487 | -0.53757 |
Other Investing Cash Flow Items, Total | 0.095 | 0.01144 | 0 | 11.7764 | |
Cash From Financing Activities | 78.966 | 20.7929 | 12.6404 | 0 | 26.4127 |
Issuance (Retirement) of Stock, Net | 79.591 | 24.5429 | 15.7654 | 0 | 23.8444 |
Issuance (Retirement) of Debt, Net | -0.625 | -3.75 | -3.125 | 0 | 2.5683 |
Net Change in Cash | 46.943 | 8.44735 | -0.24896 | -10.1541 | 24.345 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -10.785 | -46.125 | -49.6874 | -28.0449 | -11.5405 |
Cash From Operating Activities | -16.893 | -32.118 | -18.7567 | -9.75913 | -4.28206 |
Cash From Operating Activities | 0.03 | 0.116 | 0.08574 | 0.05554 | 0.02656 |
Non-Cash Items | -6.32 | 8.38 | 31.7794 | 19.2826 | 8.61713 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 0.006 | 0.00649 | 0.00649 | 0.60195 |
Changes in Working Capital | 0.182 | 5.511 | -0.93438 | -1.05234 | -1.38523 |
Cash From Investing Activities | 0.095 | 0.09454 | 0.04524 | 0 | |
Capital Expenditures | 0 | 0 | 0 | ||
Cash From Financing Activities | 0 | 78.966 | 78.7678 | 67.4347 | 66.2569 |
Issuance (Retirement) of Stock, Net | 0 | 79.591 | 79.3928 | 68.0597 | 66.8819 |
Issuance (Retirement) of Debt, Net | 0 | -0.625 | -0.625 | -0.625 | -0.625 |
Net Change in Cash | -16.893 | 46.943 | 60.1057 | 57.7208 | 61.9748 |
Other Investing Cash Flow Items, Total | 0.095 | 0.09454 | 0.04524 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Level One Partners LLC | Corporation | 9.5157 | 2772643 | 1452337 | 2021-12-31 | |
White Rock Capital Management, L.P. | Hedge Fund | 7.4574 | 2172900 | 852594 | 2021-12-31 | |
Park West Asset Management LLC | Hedge Fund | 5.0561 | 1473218 | 0 | 2022-12-31 | MED |
Hardie Robert D | Individual Investor | 4.0223 | 1172000 | 297000 | 2021-12-31 | |
Green Square Capital Advisors, LLC | Investment Advisor | 3.3874 | 987000 | 794000 | 2022-12-31 | LOW |
Valentino (Michael J) | Individual Investor | 1.6978 | 494690 | 0 | 2022-09-19 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4013 | 408320 | 733 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1618 | 338522 | -777284 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8151 | 237491 | -13361 | 2022-12-31 | LOW |
Ground Swell Capital, LLC | Investment Advisor | 0.751 | 218820 | 176311 | 2022-12-31 | HIGH |
Jane Street Capital, L.L.C. | Research Firm | 0.6607 | 192504 | 192504 | 2022-12-31 | HIGH |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.6513 | 189785 | -44319 | 2022-12-31 | LOW |
University of Texas Investment Management Company | Endowment Fund | 0.4302 | 125346 | 0 | 2022-12-31 | LOW |
HRT Financial LP | Investment Advisor | 0.2984 | 86942 | 86942 | 2022-12-31 | HIGH |
UBS Financial Services, Inc. | Investment Advisor | 0.2873 | 83723 | 27752 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.2835 | 82604 | -179302 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2716 | 79132 | 0 | 2022-12-31 | LOW |
Virtu Americas LLC | Research Firm | 0.2449 | 71368 | 71368 | 2022-12-31 | HIGH |
Ergoteles Capital | Hedge Fund | 0.2086 | 60771 | 60771 | 2022-12-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 0.187 | 54500 | 54500 | 2022-12-31 | HIGH |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Pharmaceuticals (NEC) |
9 Fishers Ln Ste E
07871-2402
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com